Latest P2P INTERVENTIONS™ News and Updates

Generics and Some Brands May Lose $7 Billion Pain Market as Pisgah Labs Develops Abuse Deterrent Products

As controversy surrounds the recent FDA decisions concerning abuse deterrent forms of oxycodone drug products, Pisgah Laboratories, Inc. (www.pisgahlabs.com) achieves …

Abuse Deterrent Technology Promises Annual Budget Savings Exceeding $200 Billion

PISGAH FOREST, N.C., March 5, 2013 — Pisgah Laboratories, Inc. has announced the launch of a new website to assist …

Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking

The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that it has selected Pisgah Laboratories’ abuse-deterrent technology …

Pisgah Laboratories Receives Patent for Innovative Abuse-Deterrent Technology Targeting Pseudoephedrine and Ephedrine

December 20, 2012—(Pisgah Forest, NC), Pisgah Laboratories, Inc., (www.Pisgahlabs.com) an innovative pharmaceutical development company located in Western North Carolina may …

Center for Lawful Access and Abuse Deterrence recognizes Pisgah Laboratories Inc for its efforts to reduce the U.S. drug abuse crisis.

Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD

Center for Lawful Access and Abuse Deterrence recognizes Pisgah Laboratories Inc for its efforts to reduce the U.S. drug abuse …

Pisgah Labs’ Invention Improves Safety of Thyroid Hormones

Today, Pisgah Labs, Inc. (www.pisgahlabs.com) received a Notice of Allowance from the United States Patent and Trademark ofﬁce (www.uspto.gov) for …

Pisgah’s approach to counter drug abuse is to re-vamp the chemistry of abused medications so as to remove the features which enable abuse—while still retaining the intended medical benefit when the drug is used properly.

Pisgah Laboratories, Inc. Scores a Triple Play in the World Series Against Prescription Drug Abuse

(Pisgah Forest, NC—November 12, 2012) Pisgah Laboratories, Inc. (www.pisgahlabs.com) has recently received three Notices of Allowance for United States Patents …

Scientists Focus Innovations to Reduce Deaths From Prescription Drug Abuse

Pisgah Laboratories, Inc., (www.pisgahlabs.com) has received Notice of Allowance from the United States Patent and Trademark Office (www.uspto.gov) for its …

Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product.

Abuse Deterrent Hydrocodone / Acetaminophen Leads NDA Pipeline

Pisgah Forest, NC—January 19. 2011. As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will …